No Data
No Data
No Data
No Data
No Data
CR Double-Crane Pharmaceutical's Profit Rises 11% in Q1 as Revenue Grows 2%
China Resources Double-Crane Pharmaceutical (SHA:600062) posted an 11% year-over-year increase in attributable net profit in the first quarter of 2024 to 416.1 million yuan from 374.9 million yuan, th
MT Newswires02:09 ET
CR Double-Crane Pharmaceutical's Unit Gets Nod to Trial New Pain Medication
China Resources Double-Crane Pharmaceutical's (SHA:600062) unit, China Resources Shuanghe Limin Pharmaceutical (Jinan), will conduct clinical trials on pregabalin extended-release tablets after receiv
MT Newswires02:04 ET
Calculating The Intrinsic Value Of Crane NXT, Co. (NYSE:CXT)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Crane NXT fair value estimate is US$70.42 With US$62.87 share price, Crane NXT appears to be trading close to its estimated fair value Our
Simply Wall StApr 25 08:38 ET
Crane Raised to Buy From Hold by Vertical Research
Crane Raised to Buy From Hold by Vertical Research
Dow JonesApr 24 15:20 ET
Express News | Vertical Research Upgrades Crane to Buy
Moomoo 24/7Apr 24 15:10 ET
Analyst Expectations For Crane's Future
In the preceding three months, 4 analysts have released ratings for Crane (NYSE:CR), presenting a wide array of perspectives from bullish to bearish.The table below summarizes their recent ratings, sh
BenzingaApr 24 15:00 ET
No Data
No Data